Valuation: COMPASS Pathways plc

Market Cap 196.64Cr 168.43Cr 157.46Cr 144.07Cr 272.03Cr 19TCr 274.65Cr 1.86TCr 723.9Cr 9.46TCr 738.27Cr 722.23Cr 31TCr P/E 2026 *
-6.92x
P/E 2027 * -8.88x
Enterprise Value 160.74Cr 137.68Cr 128.71Cr 117.77Cr 222.36Cr 15TCr 224.51Cr 1.52TCr 591.74Cr 7.73TCr 603.49Cr 590.37Cr 26TCr EV / Sales 2026 *
-
EV / Sales 2027 * 38.6x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day+4.79%
1 week+8.45%
Current month+31.10%
1 month+32.15%
3 months+25.99%
6 months+86.23%
Current year+115.65%
1 week 13.08
Extreme 13.08
14.92
1 month 10.59
Extreme 10.59
14.92
Current year 4.88
Extreme 4.88
15.4
1 year 4.4
Extreme 4.4
15.4
3 years 2.25
Extreme 2.25
15.4
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 01/08/2022
Director of Finance/CFO 54 01/03/2024
Chief Tech/Sci/R&D Officer 66 01/05/2024
Director TitleAgeSince
Chairman 74 29/03/2024
Director/Board Member 69 01/04/2020
Director/Board Member 67 01/03/2021
Date Insider Type Main position Quantity % Market Cap.
03/08/26 Tax

Chief Executive Officer

-5,962 0.0062%
26/03/26 Free

Chief Executive Officer

5,42,815 0.5658%
11/03/26 Tax

Chief Financial Officer

1,781 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
+4.79%+8.45%+222.78%+68.14% 196.64Cr
+1.02%+4.84%+4.80%+24.36% 5.12TCr
-0.09%-0.29%+471.14%+564.30% 4.53TCr
-0.32%+7.54%+35.72%+20.37% 4.28TCr
+1.18%+3.82%+19.99%+89.24% 4.23TCr
-2.27%-5.67%+14.55%+50.34% 3.22TCr
-0.96%+2.84%+32.44%+142.88% 1.73TCr
+0.41%+2.26% - - 1.65TCr
+1.12%+5.83%+8.37%+32.33% 1.48TCr
-0.31%+3.84%+83.91%+49.85% 1.43TCr
Average +0.46%+3.10%+99.30%+115.76% 2.79TCr
Weighted average by Cap. +0.08%+2.90%+102.11%+140.73%

Financials

2026 *2027 *
Net sales - 3.97Cr 3.4Cr 3.18Cr 2.91Cr 5.49Cr 378.73Cr 5.54Cr 37Cr 15Cr 190.89Cr 15Cr 15Cr 631.99Cr
Net income -30Cr -26Cr -24Cr -22Cr -41Cr -2.85TCr -42Cr -281.96Cr -109.92Cr -1.44TCr -112.1Cr -109.67Cr -4.75TCr -25Cr -22Cr -20Cr -18Cr -35Cr -2.4TCr -35Cr -237.87Cr -93Cr -1.21TCr -95Cr -93Cr -4.01TCr
Net Debt -36Cr -31Cr -29Cr -26Cr -50Cr -3.42TCr -50Cr -339.02Cr -132.16Cr -1.73TCr -134.79Cr -131.86Cr -5.72TCr -43Cr -37Cr -35Cr -32Cr -60Cr -4.12TCr -60Cr -408.11Cr -159.09Cr -2.08TCr -162.25Cr -158.73Cr -6.88TCr
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
25/26/25 $14.88 +4.79% 22,70,335
24/26/24 $14.20 +6.53% 27,76,364
21/26/21 $13.33 -3.55% 20,84,620
20/26/20 $13.82 -1.36% 20,38,389
19/26/19 $14.01 +0.79% 28,36,065
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
14.20USD
Average target price
23.75USD
Spread / Average Target
+67.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock